uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Docetaxel Mylan
Application withdrawn
Human
Details
EMA number
EMEA/H/C/001193
ATC code
-
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Not specified
MeSH:
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Head and Neck Neoplasms;Stomach Neoplasms;Adenocarcinoma;Prostatic Neoplasms
Active substances
docetaxel
Marketing Authorisation Holder
Mylan S.A.S.
MAH
Timeline
Filter by authority:
EMA
Docetaxel Mylan authorised
31 Jan 2012
authorised
regulatory
Status changed: Lapsed → Application withdrawn
26 Mar 2010
status_changed
regulatory
Docetaxel Mylan | uMedical